01 1Ipca Laboratories
01 1ETODOLAC USP (ED7 PROCESS)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-04-17
Pay. Date : 2013-09-30
DMF Number : 27512
Submission : 2013-09-21
Status : Active
Type : II
20
Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ETODOLAC USP (ED7 PROCESS), with a corresponding US DMF Number 27512.
Remarkably, this DMF maintains an Active status since its submission on September 21, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 17, 2014, and payment made on September 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
